Noriko Kanaya Selected Research

Noriko Kanaya Research Topics

Disease

16	Neoplasms (Cancer) 12/2021 - 11/2002
15	Breast Neoplasms (Breast Cancer) 12/2021 - 10/2011
4	Triple Negative Breast Neoplasms 01/2021 - 01/2014
3	Obesity 01/2018 - 10/2010
2	Neoplasm Metastasis (Metastasis) 01/2014 - 10/2011
2	Inflammation (Inflammations) 01/2014 - 10/2011
2	Body Weight (Weight, Body) 11/2013 - 10/2010
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 09/2015
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 06/2015
1	Weight Gain 11/2013
1	Glucose Intolerance 11/2013
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2011
1	Osteosarcoma (Osteogenic Sarcoma) 07/2011
1	Non-alcoholic Fatty Liver Disease 01/2011
1	Infections 07/2003
1	Lymphoma (Lymphomas) 05/2003
1	dermatophilosis 04/2003
1	Anemia 04/2003
1	Weight Loss (Weight Reduction) 04/2003

Drug/Important Bio-Agent (IBA)

9	Estrogens (Estrogen)FDA Link 12/2021 - 10/2010
6	Estrogen ReceptorsIBA 12/2021 - 09/2015
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2002
4	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2019
4	Hormones (Hormone)IBA 12/2021 - 01/2013
3	Aromatase InhibitorsIBA 01/2020 - 01/2013
3	sapanisertibIBA 04/2019 - 01/2018
3	PowdersIBA 09/2015 - 10/2011
2	Dihydrotestosterone (Androstanolone)IBA 01/2021 - 11/2013
2	TOR Serine-Threonine KinasesIBA 04/2019 - 01/2018
2	Phosphotransferases (Kinase)IBA 04/2019 - 01/2018
2	palbociclibIBA 04/2019 - 06/2018
2	Phenobarbital (Luminal)FDA Link 01/2019 - 01/2017
2	CytokinesIBA 09/2015 - 01/2014
2	ElementsIBA 06/2015 - 05/2014
2	Histone Deacetylase InhibitorsIBA 06/2015 - 01/2013
2	Aromatase (CYP19)IBA 06/2015 - 05/2014
2	PanobinostatIBA 06/2015 - 01/2013
2	LuciferasesIBA 06/2015 - 05/2014
2	AndrogensIBA 05/2014 - 11/2013
2	Messenger RNA (mRNA)IBA 07/2011 - 11/2003
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2003 - 05/2003
1	enzalutamideIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2021
1	exemestane (Aromasin)FDA Link 01/2020
1	Letrozole (Femara)FDA LinkGeneric 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2019
1	Retinoblastoma ProteinIBA 04/2019
1	Halogenated Diphenyl EthersIBA 01/2019
1	pentabromodiphenyl ether (PBDE)IBA 01/2019
1	Everolimus FDA Link 08/2018
1	Cyclin D1IBA 06/2018
1	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2018
1	Nonesterified Fatty Acids (NEFA)IBA 01/2018
1	EnzymesIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	Fulvestrant (Faslodex)FDA Link 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 09/2015
1	ErbB Receptors (EGF Receptor)IBA 09/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 09/2015
1	Epidermal Growth Factor (EGF)IBA 09/2015
1	salinomycinIBA 06/2015
1	Aldehyde Dehydrogenase 1 FamilyIBA 06/2015
1	Drug CombinationsIBA 06/2015
1	LeptinIBA 11/2013
1	Glucose (Dextrose)FDA LinkGeneric 11/2013
1	Caspase 3 (Caspase-3)IBA 10/2011
1	Glycogen Synthase (Synthase I)IBA 10/2011
1	CateninsIBA 10/2011
1	Interleukin-13IBA 10/2011
1	salicylhydroxamic acid (SHAM)IBA 10/2010
1	Conjugated Linoleic AcidsIBA 10/2010
1	beta-Galactosidase (Lactaid)IBA 07/2003
1	SolutionsIBA 07/2003
1	Complementary DNA (cDNA)IBA 05/2003
1	CholesterolIBA 04/2003
1	Blood Proteins (Serum Proteins)IBA 04/2003
1	AntibodiesIBA 11/2002
1	AntigensIBA 11/2002

Therapy/Procedure

5	Therapeutics 06/2018 - 07/2011
1	Hair Removal (Depilation) 04/2003